Classical neurotransmitters are mainly known for their roles as neuromodulators, but they also play important roles in the control of developmental and regenerative processes. Here, we used the lamprey model of spinal cord injury to study the effect of serotonin in axon regeneration at the level of individually identifiable descending neurons. Pharmacological and genetic treatments after a complete spinal cord injury showed that endogenous serotonin inhibits axonal regeneration in identifiable descending neurons through the activation of serotonin 1A receptors and a subsequent decrease in cAMP levels. RNA sequencing revealed that changes in the expression of genes that control axonal guidance could be a key factor on the serotonin effects during regeneration. This study provides new targets of interest for research in nonregenerating mammalian models of traumatic CNS injuries and extends the known roles of serotonin signalling during neuronal regeneration.
Introduction
In contrast to mammals, including humans, lampreys recover locomotion spontaneously following a complete spinal cord injury (SCI; see [1] [2] [3] [4] ). In lampreys, the process of recovery from SCI involves a positive astroglial response 5 , the production of new neurons in the spinal cord 6 and the regeneration of ascending and descending axons through the injury site [7] [8] [9] [10] . This regeneration is specific in that axons grow selectively in their normal directions 7, 11, 12 . Moreover, regenerated axons of descending brain neurons are able to re-establish synaptic connections with their appropriate targets below the site of injury 13, 14 . However, even in lampreys not all descending neurons of the brain are able to regenerate their axons following a complete spinal cord transection, even when normal appearing locomotor function is observed several weeks after the injury 8,9 . Approximately, 50% of all descending brainstem neurons are able to regenerate their axon below the site of injury after a complete SCI 14, 15 . Among brain descending neurons, the brainstem of lampreys contains several giant individually identifiable descending neurons that vary greatly in their regenerative ability, even when their axons run in similar paths in a spinal cord that is permissive for axonal regrowth 9 . Some identifiable neurons like the Mauthner or I1 neurons regenerate their axon less than 10% of the times after a complete spinal cord transection, while other identifiable neurons like the I3 or B6 neurons are able to regenerate their axon more than 60% of the times after a complete SCI 9 . This suggests that intrinsic factors present in some neurons but not in others might limit their regenerative ability. Lampreys offer a convenient vertebrate model in which to study the inhibition or promotion of axonal regeneration after SCI in the same in vivo preparation.
One of the main molecules known to be an intrinsic regulator of axonal regeneration is the second messenger cyclic-adenosine monophosphate (cAMP) (see 4 16, 17 ). Several reports in mammals and fishes have shown that cAMP promotes axon regeneration following SCI [18] [19] [20] [21] [22] . Subsequent studies have also shown that cAMP promotes axon regeneration in descending neurons of lampreys after SCI [23] [24] [25] . The challenge now is to define the signals that control cAMP levels in descending neurons after axotomy and during regeneration.
Several neurotransmitters modulate intracellular cAMP levels by activating metabotropic G-protein coupled receptors, which include serotonin, glutamate, GABA or dopamine receptors. So, neurotransmitters acting through these receptors are potential regulators of intracellular cAMP levels following a traumatic injury to the CNS. Among them, serotonin appears as a good candidate to regulate axon regeneration following nervous system injuries (see 26 ). Serotonin receptors are divided in 7 families, with families 1, 2 and 4 to 7 being G-protein coupled metabotropic receptors and type 3 serotonin receptors being ligand-gated ion channels. Families 1 and 5 of serotonin receptors are known to decrease intracellular levels of cAMP; whereas, families 4, 6 and 7 increase intracellular levels of cAMP. A few in vitro and ex vivo studies have shown that serotonin inhibits axon regrowth in invertebrate 27, 28 and vertebrate 29, 30 species. In contrast, a recent in vivo study in Caenorhabditis elegans showed that 5-HT promotes axon regeneration after axotomy 31 . However, no study has yet looked at the role of serotonin in axon regeneration in a in vivo vertebrate model of traumatic CNS injury.
The presence of rich serotonin innervation in the vicinity of descending neurons of the lamprey brainstem 32, 33 , the expression of serotonin 1A receptors in identifiable descending neurons of lampreys 34 and data showing an increase in synaptic contacts on descending neurons following SCI in lampreys 35 prompted us to study the possible role of serotonin in axon regeneration following SCI in lampreys. Here, we present gain and loss of function data using pharmacological and genetic treatments showing that endogenous serotonin inhibits axon regeneration in identifiable descending neurons of lampreys following a complete SCI by activating serotonin 1A receptors. We also performed an RNA sequencing study, which revealed that changes in the expression of genes that control axonal guidance could be a key factor on the serotonin effects during regeneration. This provides a new target of interest for SCI research in non-regenerating mammalian models.
Results

A serotonin treatment inhibits axon regeneration in identifiable descending neurons after a complete spinal cord injury
To reveal the effect of serotonin in the regeneration of identifiable descending neurons, larval sea lampreys were treated with the serotonin analogue serotoninhydrochloride for a month following a complete spinal cord transection. At 11 weeks post-lesion (wpl), the serotonin treatment significantly inhibited axon regeneration of identifiable descending neurons of the sea lamprey (Student's t-test, p = 0.0145; Fig. 1A-C). Interestingly, behavioural analyses revealed that the serotonin treatment did not cause a general toxic effect since locomotor recovery was not affected by the serotonin treatment ( Fig. 1D ).
cAMP treatment can reverse the inhibitory effect of serotonin on axonal regeneration
Previous studies have shown that a single dose of cAMP applied at the time of transection promotes axon regeneration of identifiable descending neurons following a complete spinal cord transection in larval sea lampreys [23] [24] [25] . Here, and to reveal a possible involvement of this second messenger in the inhibitory effect of serotonin in axonal regeneration, we carried out a rescue experiment in which animals treated with 6 serotonin as above were also treated with dibutyryl-cAMP (db-cAMP). The db-cAMP treatment was able to significantly rescue the inhibitory effect of serotonin, with these animals reaching levels of axonal regeneration of identifiable descending neurons similar to control vehicle treated animals (ANOVA, p = 0.0288, Fig. 1A, B and E).
Correlation between the expression of 5-HT1A and the regenerative ability of identifiable neurons
The serotonin 1A receptor is an ancient G-protein coupled receptor that is known to decrease intracellular cAMP levels through Gi/Go when activated by serotonin. In a previous study, we showed that this receptor is expressed in identifiable descending neurons of larval sea lampreys 34 . This, together with the results of the db-cAMP treatments (see previous section) prompted us to study whether there was a correlation between the expression of the serotonin 1A receptor in identifiable descending neurons and their known regenerative ability following a complete spinal cord transection. First, qPCR analyses of the whole brainstem (where most descending neurons are located) revealed no significant changes in the expression of the serotonin 1A receptor 4 wpl as compared to control animals (Suppl. Fig. 1 ). We should take into account that the brainstem contains a large number of non-descending neurons and also that only about 50% of descending neurons of the lamprey brainstem regenerate after a complete spinal cord transection (see introduction). So, we decided to carry out in situ hybridization analyses in horizontal sections of the sea lamprey brain to look at the expression of the serotonin 1a receptor in individually identifiable neurons. This, as opposed to whole-mounts, impedes the clear identification of all identifiable descending neurons in all sections; therefore, in these analyses only the M1, M2, M3, I1 and I3 neurons where included. 7 Our in situ hybridization experiments revealed that in bad regenerator neurons (neurons that regenerate their axon less than 30% of the times) there is a significant increase in the expression of the serotonin 1A receptor 4 weeks after a complete SCI (M2 neuron: Kruskal-Wallis, p = 0.0105; M3 neuron: ANOVA, p = 0.0478; I1 neuron: ANOVA, p = 0.0238; Fig. 2A ; Table 1 ), while in good regenerator neurons (M1 and I3 neurons) the expression of the receptor decreases (non-significantly) in the first weeks following a complete spinal cord transection ( Fig. 2B ; Table 1 ). Statistical analyses revealed a significant correlation between the percentage of increase/decrease in the expression of the receptor 4 wpl and the long-term regenerative ability of identifiable neurons (Pearson's test, p = 0.0293, Fig. 2C ). This suggests that the presence and activity of this receptor in descending neurons might inhibit axonal regeneration after a complete SCI.
Endogenous serotonin inhibits axon regeneration through the 5-HT1A receptor following SCI
Based on the in situ hybridization results, we decided to study whether endogenous serotonin inhibits axon regeneration of identifiable descending neurons by activating serotonin 1A receptors. For this, we treated animals after a complete spinal cord transection with the serotonin 1A receptor antagonist WAY-100,135. Spinal cord transected animals were treated with WAY-100,135 for 4 weeks following a complete spinal cord transection. The WAY-100,135 treatment significantly promoted axon regeneration 11 wpl in identifiable neurons compared to control vehicle treated animals (Student's t-test, p = 0.049, Fig. 3A -C). This indicates that endogenous serotonin inhibits axon regeneration following a complete SCI by activating serotonin 1A receptors. 8 To confirm that the inhibitory effect of endogenous serotonin is due to the activation of serotonin 1A receptors expressed in identifiable descending neurons we decided to specifically knock-down the expression of the receptor in these neurons by using morpholinos targeted against the translation initiation site of the 5-HT1A receptor sequence (Suppl. Fig. 2A ). The morpholinos were applied at the time of transection on the rostral stump of the spinal cord. Fluorescent labelling of the morpholinos confirmed that these were retrogradely transported and reached the soma of descending neurons during the first wpl (Suppl. 
The WAY-100,135 treatment increases cAMP levels in the brainstem
To study whether changes in cAMP levels might be behind the beneficial effects of the serotonin 1A receptor antagonist treatments another set of animals was treated with WAY-100,135 for 1 week. A cAMP detection assay of the whole-brainstem revealed that the antagonist treatment, which also promoted axonal regeneration (see previous section), significantly increased cAMP levels in the brainstem (Mann-Whitney 9 U test, p = 0.0397; Fig. 3G ). This result indicates that the inhibition of axon regeneration caused by the activation of serotonin 1A receptors by endogenous serotonin might be caused by a decrease in intracellular levels of cAMP.
RNA sequencing following WAY-100,135 treatment reveals new signalling pathways possibly involved in axonal regeneration in lampreys
Our gain and loss of function experiments revealed that endogenous serotonin inhibits axon regeneration following SCI in the sea lamprey through the activation of serotonin 1A receptors and that this effect might be caused by a decrease in intracellular cAMP levels. To reveal new genes that might be involved in the intrinsic control of axon regeneration and whose expression is modulated by the activity of 1A receptors we decided to repeat the WAY-100,135 treatment and carry out an RNA sequencing study in the sea lamprey brainstem at 4 wpl.
A total of 61 differentially expressed genes were detected between WAY-100,135 treated samples and control vehicle treated animals (Figure 4 , Supplementary   Table 1 ). Most of these genes were found down-regulated after WAY-100,135 treatment (5 up-regulated genes, 56 down-regulated). Among these down-regulated genes in response to WAY-100,135 is Plexin-B1 (PLXNB1, logFC = -0.42), which plays a role in axon guidance and works as a transmembrane receptor for semaphorins 36 . Only one of the five significantly up-regulated genes was annotated, Glutamine synthetase (GLUL, logFC = 1.05). This gene is primarily found in astrocytes and protects neurons against excitotoxicity 37 . Pathway analysis using Reactome 38 revealed 29 significantly enriched pathways (FDR p-value < 0.05; Supplementary Table   2 ). Among these, the most interesting ones are "Axon guidance", "Signalling by ROBO 1 0
receptors" and "Regulation of expression of SLITs and ROBOs", which are represented only by down-regulated genes.
Discussion
We have provided gain and loss of function evidence, using pharmacological and genetic treatments, showing that endogenous serotonin inhibits axon regeneration after SCI in lampreys by activating serotonin 1A receptors expressed in descending neurons. Our results also suggest that differential changes in serotonin 1A receptor expression in descending neurons could be one of the factors that explain the different regenerative abilities of individual descending neurons.
Only a few studies have previously looked at the possible role of serotonin in neurite/axon regeneration and these have been carried out only in invertebrate and in vitro models (see 26 ). Koert and co-workers 28 showed that in the snail Lymnaea stagnalis auto-released serotonin inhibited neurite outgrowth in cultured serotonergic cerebral giant cells. An ex vivo study in the pond snail (Helisoma trivolis) showed that the spontaneous regeneration of specific neurons was inhibited by serotonin treatments 27 .
Serotonin or serotonin reuptake inhibitor treatments also inhibited neurite outgrowth from goldfish retinal explants with a previous crush to the optic nerve 29, 30 . So, our results confirm these previous in vitro studies and show that endogenous serotonin inhibits axon regeneration after a traumatic injury in vivo and in a vertebrate species.
The only exception to these results comes from a recent study showing that in the nematode Caenorhabditis elegans serotonin promotes axon regeneration 31 . In these animals, non-serotonergic neurons temporarily express tryptophan hydroxylase (the rate-limiting enzyme in serotonin synthesis) in response to axotomy promoting their regeneration 31 . We should take into account that serotonin can signal through a variety 1 1 of serotonin receptors that activate different secondary pathways. Our results showed that in lampreys the negative effect of endogenous serotonin on the regeneration of descending neurons is caused by the activation of serotonin 1A receptors and a subsequent reduction in cAMP levels. Previous in vitro studies in goldfish also showed that the activation of serotonin 1A receptors inhibits neurite outgrowth 29, 39 .
Accordingly, serotonin 1A agonist treatments reduced neurite outgrowth from retinal explants of goldfish with a prior crush of the optic nerve 29, 39 . Interestingly, in C. elegans the opposite effect of serotonin was mediated by the activation of serotonin 7 receptors, since mutations of this receptor caused defects in axon regeneration after axotomy 31 .
Notably, Alam and co-workers 31 showed that the positive effect of the activation of this receptor was caused (at least partially) by the stimulation of adenylate cyclase to produce cAMP. Taken together, present and previous results indicate that serotonin is an important regulator of axon regeneration by modulating cAMP levels and that the effects of serotonin will depend on the preferential use of different types of serotonin receptors in different neurons.
Our RNA sequencing study also revealed changes in gene expression in the brainstem associated to serotonin 1A receptor signalling after a complete SCI. Of interest, a treatment with a serotonin 1A receptor antagonist (which increases cAMP levels and promotes axon regeneration) reduced the expression of genes associated to the regulation of axonal guidance. Specifically, Plexin-B1 was one of the most significantly downregulated genes together with the pathways "Signalling by ROBO receptors" and "Regulation of expression of SLITs and ROBOs". Interestingly, previous work in lampreys has suggested that the expression/activity of some receptors that participate in axonal guidance inhibits axonal regeneration after SCI in identifiable neurons (e.g. UNC5 [40] [41] [42] ). Also, a previous study already suggested a possible 1 2 involvement of semaphorin/plexin signalling in recovery after SCI in lampreys based on the occurrence of changes in the expression of semaphorins in the spinal cord after the injury 43 . Future studies should functionally test the possible involvement of Slits and semaphorins in the inhibition of axonal regeneration in descending neurons after SCI in lampreys.
Present and previous work in regenerating species shows that serotonin plays different roles in the process of regeneration after SCI. In zebrafish, endogenous serotonin promotes motor neuron production in the spinal cord after a complete SCI by enhancing the proliferation of motor neuron progenitor cells 44 . In turtles, serotonin inhibits the emergence of serotonergic interneurons after SCI by inhibiting a change in neurotransmitter phenotype of non-serotonergic neurons 45 . On the other hand, the production of new-born serotonergic neurons in the spinal cord of zebrafish after SCI is not affected by endogenous serotonin 44 . Here, our results show that in regenerating vertebrates endogenous serotonin also controls axon regeneration of descending neurons after SCI. This indicates that serotonin could also be a target of interest in nonregenerating mammalian models of SCI since it can modulate several aspects of the regenerative process. Even more importantly the effects of serotonin revealed in these studies should be taken into account by those authors performing pharmacological treatments with serotonergic drugs to modulate spinal cord circuits and aiming to promote locomotor recovery after SCI (see 46 ), mainly because these treatments could be affecting the regeneration of new neurons or the re-growth of axotomized axons as shown here.
Experimental procedures
Animals 1 3 All experiments involving animals were approved by the Bioethics Committee at Mature and developmentally stable larval sea lampreys, Petromyzon marinus L.
(n = 176; between 90 and 120 mm in body length, 5 to 7 years of age), were used in the study. Larval lampreys were collected from the river Ulla (Galicia, north-western Spain), with permission from the Xunta de Galicia, and maintained in aerated fresh water aquaria at 15 °C with a bed of river sediment until their use in experimental procedures. Larval lampreys were randomly distributed between the different experimental groups.
Spinal cord injury surgical procedures
Larval sea lampreys were assigned to the following experimental groups: control animals without a complete spinal cord transection or animals with a complete spinal cord transection that were analysed 1 wpl, 4 wpl or 11 wpl. Within some of the 4 wpl and 11 wpl groups the animals were assigned to either a vehicle treated control group or to a treatment group. Table 2 summarizes the number of animals assigned to each experimental group. Each experiment was carried out in at least 2 different batches of animals. Complete spinal cord transections were performed as previously described 47 . 1 4 Briefly, the spinal cord was exposed from the dorsal midline at the level of the 5 th gill by making a longitudinal incision with a scalpel (#11). A complete spinal cord transection was performed with Castroviejo scissors and the spinal cord cut ends were visualized under the stereomicroscope. Then, the animals were kept on ice for 1 hour to allow the wound to air dry. After this hour, the animals were returned to fresh water tanks and each transected animal was examined 24 hours after surgery to confirm that there was no movement caudal to the lesion site. Then, the animals were allowed to recover in fresh water tanks at 19.5 ºC and in the dark.
Drug treatments
The following drugs were used to treat the animals following the complete spinal cord transection: serotonin-hydrochloride (a serotonin analogue that crosses the blood brain barrier; AlfaAesar; Cat#: B21263; MW: 212.68 g/mol), WAY-100,135 (a 5-HT1A antagonist that crosses the blood brain barrier; Sigma; Cat#: W1895; MW: as previously described by other authors 23, 24 . Gelfoam soaked in the same volume of lamprey Ringer's solution served as a control.
We assumed that these drugs also crossed the blood brain barrier in lampreys as in mammals, since the blood brain barrier of lampreys is similar to that of higher vertebrates 48, 49 . Serotonin was applied at the same concentration previously used by other authors 46 . Becker and Parker 46 already reported that this concentration of serotonin affects the swimming behaviour of lesioned and unlesioned animals indicating that this application route also allows access to the CNS. We also observed changes in the swimming behaviour of unlesioned animals in pilot experiments using WAY-100,135 at this concentration (not shown). For db-cAMP application we followed the protocol used by other authors in lampreys in studies in which this treatment promoted axonal regeneration after SCI 23, 24 . 
Δ Δ
CT method was used with 1 6 the controls as normalizer, and the Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as reference gene. Primer sequences for serotonin 1a receptor and gapdh can be found in Supplementary Table 3 . Reactions were performed using a qPCR Master Mix Plus SYBR Green I No Rox (Eurogenetec; Liege, Belgium) following the manufacturer instructions and qPCR was carried out on a MX3005P (Agilent Technologies; Santa Clara, CA), including two technical replicates of each sample.
Analyses were performed using the MxPro software. Fig. 2B ; 42, [51] [52] [53] [54] ). The GeneTools standard control morpholino has been already used in previous studies using morpholino treatments after SCI in lampreys 51, 53 . Animals were allowed to recover for 1, 4 or 11 wpl.
In situ hybridization
Immunofluorescence experiments were carried out to confirm that the active serotonin 1A receptor morpholino decreases the expression of the sea lamprey receptor. Fig. 2E ).
Behavioural analyses
The behavioural recovery of the animals treated with serotonin-hydrochloride was analysed at 11 wpl based on the study of Ayers 55 differential expression were performed using R v.3.4.3 (R Core Team 2014). Gene count data were used to estimate differential gene expression using the Bioconductor package DESeq2 v.3.4 60 . The Benjamini-Hochberg false discovery rate (FDR) was applied, and transcripts with corrected p-values < 0.05 were considered differentially expressed genes. Heatmaps were drawn using the R package "gplots" v.3.01.1 61 .
Pathway analyses were performed using Reactome 38 , converting all non-human gene identifiers to their human equivalents.
Imaging and quantifications
The percentage of neurons with regenerated axons (labelled by the Neurobiotin tracer) respect to the total number of analysed neurons (see Table 1 ) was calculated for each type of identifiable descending neuron using an Olympus microscope. The percentage of neurons with regenerated axons respected to the total number of analysed neurons in each animal was also calculated and these data was used for statistical analyses. The experimenter was blinded during quantifications. For the figures, images were taken with a spectral confocal microscope (model TCS-SP2; Leica).
An Olympus photomicroscope (AX-70; Provis) with a 20x Apochromatic 0.75 lens and equipped with a colour digital camera (Olympus DP70, Tokyo, Japan) was used to acquire images of brain sections from the in situ hybridization experiments.
Images were always acquired with the same microscope and software settings. The quantification of the level of serotonin 1a receptor positive signal in identifiable descending neurons was performed as previously described 54 . First, we established the intensity rank of positive colorimetric in situ signal. For this, we analysed 10 random images from different descending neurons of control and lesioned animals. The "histogram" function in Image J shows the number of pixels in each image in a range of 2 2 intensity from 0 to 255. With these images, we compared the intensity values in regions with clear in situ signal and the intensity values in regions without in situ signal. Based on this, we established a value of 179 as the lower limit to consider the colorimetric in situ signal as positive. Then the number of pixels of positive in situ signal was quantified for each section of each identified descending neuron. In horizontal brain sections, the identification of some of the specific descending cells becomes more difficult than in whole-mounts. Thus, only the cells that were unequivocally identified in at least two different sections were included in the quantifications (the M1, M2, M3, I1 and I3 neurons; see Suppl. Fig. 3 ). Then, we calculated the average number of positive pixels per section for each individual neuron (see Table 1 ) and this data was used for statistical analyses. The experimenter was blinded during quantifications. 
Statistical analyses
Statistical analysis was carried out using Prism 6 (GraphPad software, La Jolla, Gene expression is represented as regularized log-transformed read counts scaled by gene. Samples (x-axis) and genes (y-axis) were hierarchically clustered according to their gene expression Euclidian distances using complete linkage clustering. group and also the total number of identifiable descending neurons that were included in the analyses.
Tables
Note that in the in situ hybridization experiments only the neurons that were unequivocally identified in at least 2 brain sections were included in the quantifications. 
Total number of neurons included in the analyses
